Zura Bio Ltd (ZURA)
2.77
-0.16
(-5.46%)
USD |
NASDAQ |
Nov 22, 11:50
Zura Bio Total Liabilities (Quarterly): 18.24M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 18.24M |
| June 30, 2024 | 17.44M |
| March 31, 2024 | 16.27M |
| December 31, 2023 | 21.29M |
| September 30, 2023 | 18.96M |
| Date | Value |
|---|---|
| June 30, 2023 | 22.01M |
| March 31, 2023 | 6.53M |
| September 30, 2022 | 14.70M |
| June 30, 2022 | 14.02M |
| March 31, 2022 | 12.54M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.53M
Minimum
Mar 2023
22.01M
Maximum
Jun 2023
16.20M
Average
16.85M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 10.68M |
| IGC Pharma Inc | 2.992M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Protalix BioTherapeutics Inc | 29.13M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 189.07M |
| Shareholders Equity (Quarterly) | 153.05M |